Pay in 4 interest-free payments of $5.38 Learn more
Ships within 48 hours · Estimated delivery Aug 16 - Aug 21
Oral/buccal protocols: Continuous daily use is the standard documented approach for oral and buccal routes.
Like Wegovy, Saxenda may be prescribed to adults and children with obesity, as well as adults who are overweight and have at least one weight-related health condition
FDA Submission Timeline Based on the TRIUMPH-4 success and expected 2026 readouts, analysts predict: Late 2026: Completion of core TRIUMPH trials Q4 2026 or Q1 2027: New Drug Application (NDA) submission to FDA Mid to Late 2027: Potential FDA approval Early 2028: Commercial launch Eli Lilly has not officially confirmed these timelines, but the company has indicated it will submit for regulatory approval once sufficient Phase 3 data is available
It's kind of surreal how well this works. Alexander M
In phase 3 clinical trials, Novo Nordisks semaglutide showed an average weight loss of 10-15% of body weight when the medication was used for 68 weeks
Every individual responds differently to these medications
